new oral antifungal called Spriafil

July 2007

You'll see a new oral antifungal called Spriafil in Canada.

Spriafil (posaconazole) works at least as well as fluconazole or itraconazole to PREVENT Aspergillus and Candida infections in patients who are immunocompromised.

It will also be used to TREAT certain fungal infections that don't respond to other drugs.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter Canada includes:

12 issues every year, with brief articles about new meds and hot topics
200+ CE courses, including the popular CE-in-the-Letter
Quick reference drug comparison charts
Access to the entire archive

Subscribe Today!

Already a subscriber? Log in

Volume pricing available. Get quote

Is Avandia a flawed drug, or was the big new study flawed
Supplements Canadian Cancer Society upped their vitamin D recommendations
Oral Health What should you put in "magic mouthwash"
how to manage high-altitude illnesses
Infectious Diseases new oral antifungal called Spriafil
Infectious Diseases patients asking about drug-resistant tuberculosis
Infectious Diseases antibiotic prophylaxis for patients with prosthetic joints
Travel Medicine additional precautions for patients travelling while they are immunocompromised
Gastroenterology Nexium (esomeprazole) is the first proton pump inhibitor approved for "on-demand" use
Lyme Disease New guidelines will influence the treatment of Lyme disease
Obesity & Weight Loss Alli, (AL-eye), the new OTC orlistat for weight loss
long-acting naproxen called Naprelan

new oral antifungal called Spriafil

Get concise advice on drug therapy, plus unlimited access to CE

Table of Contents